Olerup has been acquired by CareDx

On April 14, 2016, Allenex, the parental company of Olerup, was acquired by CareDx, Inc. (Nasdaq: CDNA). CareDx is a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic surveillance solutions for transplant patients and has since ten years provided services to transplant patients through its AlloMap product (read more about AlloMap here).

Though acquired by CareDx the Olerup team will remain to be your partner. We continue to ensure that our customers receive high class products, delivered on time and supported by a Technical Support division providing expert help when needed.

caredx-news.jpg Knapp_watch_you-tube_Qtype_2.PNG


Olerup SSP Genomic HLA Typing products continue to set the standard after more than 20 years.        




Gamma-Type™, brought to you through collaboration between Olerup and Conexio Genomics.



Assign™SBT and SBT Resolver™,       brought to you through collaboration between Olerup and Conexio Genomics.



Antibody Detection

Antibody Detection is more than HLA. Olerup provides XM-ONE® for HLA and non-HLA crossmatching using donor endotelial precursor cells.


Highlighted meeting


Olerup and CareDx have come together to bring you new, innovative products for pre- and post- transplant diagnostics.  As always we will be present at EFI as Platinum Sponsors!   

Date: May 30 - June 2, 2017

Location: Mannheim, Germany